NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/07/2026
Back to search
Official data from USPTO
T-THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
T-THERAPEUTICS
ST13
US500000098081081Class
5, 9, 42, 44
Filing
98081081
Registration
8330457
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
07/07/2026
Trademark type
Word
Nice classes
5, 9, 42, 44
Filing date
07/12/2023
Registration date
07/07/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/07/2026
Last transaction
07/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Cambridge, GB
Examiner
ANDERSON, DANIELLE LYNN
Law office
M40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
T-Therapeutics Limited
Representatives
Stacy J. Grossman Law Office of Stacy J. Grossman PLLC
Technical classification
Nice Classes
Class 5Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the protection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; pharmaceutical preparationsin particularchemical and biological preparations for medical purposesfor the protection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; chemical preparations for use in DNA analysis for medical purposes; DNA synthesis inhibitors for medical purposespharmaceutical preparations for the protection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; biological preparations for the treatment of cancer; biological preparations for the treatment of viral and bacterial infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use for the treatment of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; immunotherapeutic drugs namelypharmaceutical preparations for the protection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes; excluding preparations for RNA-based gene silencing
Class 9
Downloadable computer software for use in collectinganalyzing and organizing data in the field of pharmaceuticalsbiopharmaceutical drug development and genome engineering; downloadable computer software for use in collectinganalyzing and organizing data in the field of scientific and pharmaceutical research and development; downloadable software for scientific modelling of pharmaceuticals in the field of scientific and pharmaceutical research and development; downloadable software for pharmaceutical modelling; downloadable software for research and development in the nature of collectinganalyzing and organizing data in the field of antibodies; devices for analyzing genome informationlaboratory devices for detecting genetic sequences; downloadable software for performing gene sequencing research and visualizationscientific analysis of genetic sequences; downloadable software for the managinganalysisvisualization of biological data; excluding software and devices for RNA-based gene silencing and hepatocyte-specific computational biology
Class 42
Scientific and technological servicesscientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for protection from infectionscancerdisease or inflammation; technical research in the field of pharmaceutical studies; design and development of computer hardware and software; platform as a service (PAAS) featuring computer software platforms for use in database management in the field of pharmaceuticalsbiopharmaceutical drug development and genome engineering; platform as a service (PAAS) featuring DNA analysis software platforms; software as a service (SAAS) services featuring software for use in database management in the field of pharmaceuticalsbiopharmaceutical drug development and genome engineering; software as a service (SAAS) services featuring DNA analysis software; provision of online non-downloadable software for the managementvisualization and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; DNA analysis services in the field of DNA sequencing for scientific research; provision of a web hosting platform for the analysis of DNA sequencing data for scientific research purposes and diagnostic and treatment purposes; excluding services related to RNA-based gene silencing and hepatocyte-specific computational biology
Class 44
Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health care services relating to DNAgeneticsgenetic pathogen testing for diagnostic or treatment purposes; medical screening and assaying in the nature of medical laboratory analysis services relating to the treatment of persons; DNA screening for medical purposes; DNA analysis services in the field of DNA sequencing for diagnostic and treatment purposes provided by medical laboratories
Publications
History of USPTO decisions and trademark events.
41 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/19/2026
PUBO
PUBLISHED FOR OPPOSITION
05/19/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/13/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/21/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
04/21/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/21/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
04/21/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/21/2026
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
01/01/2026
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/30/2025
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/20/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/28/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/28/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/28/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/16/2024
GNSL
LETTER OF SUSPENSION E-MAILED
12/16/2024
CNSL
SUSPENSION LETTER WRITTEN
12/16/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/07/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
10/09/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
10/09/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/10/2024
GNRT
NON-FINAL ACTION E-MAILED
07/10/2024
CNRT
NON-FINAL ACTION WRITTEN
07/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/11/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/31/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/31/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/31/2024
GRML
CORRESPONDENCE E-MAILED
03/27/2024
CNRT
NON-FINAL ACTION WRITTEN
03/27/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/27/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/27/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/27/2024
DOCK
ASSIGNED TO EXAMINER
03/20/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/10/2023
NWAP
NEW APPLICATION ENTERED
07/15/2023
Continuous trademark protection
Get notified about every new filing that threatens T-THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.